Cipla faces downgrade after USFDA warning letter
B&K Securities airs concerns considering Cipla’s significant exposure to the US market, constituting 28% of consolidated sales
Source: businesstoday.in
Usfda Warning Letter News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Usfda Warning Letter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Usfda Warning Letter Today - Breaking & Trending Today
Cipla slumps nearly 8% after USFDA warning letter for manufacturing lapses
After an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company's methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to good manufacturing practices, and that its drug products are adulterated.
Source: indiatimes.com
FDA warning letter puts maker of nicotine gummies in a sticky situation
The FDA issued a warning letter about nicotine gummies—the first ever notification sent for such a product. The agency’s concern is that the flavored gummies resemble candy and pose a toxicity risk to children.
Source: medcitynews.com
FDA Cites Company Over 'Illegal' Flavored Nicotine Gummies: 'Public Health Crisis Just Waiting'
This is said to be the "first warning letter for this type of product."
Source: ibtimes.com
Amazon Among 3 Companies Cited By FDA Over Fake Mole, Skin Tag Removal Products
"There are no FDA-approved over-the-counter drug products for the removal of moles and skin tags," the FDA said.
Source: ibtimes.com